DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 7-8, 2014, Pages 352-358

  Szymczak, Izabela ^a   Śliwińska, Agnieszka ^a   Drzewoski, Józef ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Colorectal cancer; DNA damage; DNA repair; Oxidative stress; Type 2 diabetes

Indexed keywords

DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; HYDROGEN PEROXIDE; ANTIOXIDANT;

AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME THERAPY; FEMALE; HUMAN; HYPERGLYCEMIA; LYMPHOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPLICATION; DRUG EFFECTS; METABOLISM;

ANTIOXIDANTS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COMET ASSAY; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; HUMANS; HYDROGEN PEROXIDE; LYMPHOCYTES; MALE; OXIDATIVE STRESS;

EID: 84906875952     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2337     Document Type: Article

References (36)

1. Habib SL, Rojna M. Diabetes and risk of cancer. ISRN Oncol. 2013; 2013: 583786.
2. th edition Update 2012. http://www.idf.org/diabetesatlas/5e/Update2012. Accessed October 2013.
3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94: 311-321.
4. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005; 28: 1805-1807. (Pubitemid 40923101)
5. Schoen RE, Weissfeld JL, Kuller LH, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology. 2005; 129: 464-475. (Pubitemid 41096634)
6. Sliwinska A, Drzewoski J. Type 2 diabetes mellitus and cancer. Experimental and Clinical Diabetology. 2007; 7: 268-275. (Pubitemid 351269728)
7. Eddi R, Karki A, Shah A, et al. Association of type 2 diabetes and colon adenomas. J Gastrointest Cancer. 2012; 43: 87-92.
8. Siddiqui AA, Maddur H, Naik S, Cryer B. The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus. Dig Dis Sci. 2008; 53: 1042-1047. (Pubitemid 351379833)
9. Sliwinska A, Blasiak J, Kasznicki J, Drzewoski J. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). Chem Biol Interact. 2008; 173: 159-165.
10. Brownlee M. Biochemistry and molecular cell biology of diabetes complication. Nature. 2001; 414: 813-820. (Pubitemid 34000785)
11. Merzouk S, Hichami A, Madani S, et al. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys. 2003; 22: 15-27. (Pubitemid 36748377)
12. Hazra TK, Das A, Das S, et al. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst). 2007; 6: 470-480. (Pubitemid 46357682)
13. Blasiak J, Arabski M, Krupa R, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004; 554: 297-304. (Pubitemid 39140837)
14. Anisimov VN. Ageing and the mechanisms of carcinogenesis: some practical implications. J Exp Clin Cancer Res. 1998; 17: 263-268. (Pubitemid 29090367)
15. da Silva BS, Rovaris DL, Bonotto RM, et al.: The influence on DNA damage of glycaemic parameters, oral antidiabetic drugs and polymorphisms of genes involved in the DNA repair system. Mutagenesis. 2013; 28: 525-530.
16. Pang J, Xi C, Dai Y, et al. Altered expression of base excision repair genes in response to high glucose-induced oxidative stress in HepG2 hepatocytes. Med Sci Monit. 2012; 18: 281-285.
17. American Diabetes Association Clinical Practice Recommendations. Standards of medical care for patients with DM. 2012; 35: 11-63.
18. American Cancer Society. Colorectal Cancer Early Detection. http://www.cancer.org/acs/groups/cid/documents/webcontent/003 170-pdf.pdf. Accessed November 2013.
19. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175: 184-191.
20. Klaude K, Eriksson S, Nygren J, Ahnström G. The comet assay: mechanisms and technical considerations. Mutat Res. 1996; 363: 89-96. (Pubitemid 26225011)
21. Blasiak J, Gloc E, Wozniak K, et al. Free radicals scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat Res. 2003; 535: 25-34. (Pubitemid 36120758)
22. David-Cordonnier MH, Laval J, O'Neill P. Clustered DNA damage, influence on damage excision by XRS5 nuclear extracts and Escherichia coli Nth and Fpg proteins. Biol Chem. 2000; 275: 11865-11873. (Pubitemid 30237755)
23. Collin AR, Duthie SJ, Dobson VL. Direct enzymatic detection of endogenous base damage in human lymphocyte DNA. Carcinogenesis. 1993; 14: 1733-1735. (Pubitemid 23290881)
24. Tudek B, VanZeeland AA, Kusmierek JT, Laval J. Activity of Escherichia coli DNA-glycosylase on DNA damaged by methylating and ethylating agents and influence of 3-substituted adenine derivatives. Mutat Res. 1998; 407: 169-176. (Pubitemid 28241558)
25. Rehman A, Nourooz-Zadeh J, Möller W, et al. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett. 1999; 448: 120-122. (Pubitemid 29151642)
26. Al-Aubaidy H., Jelinek H.F. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011; 164: 899-904.
27. Ribeiro ML, Priolli DG, Miranda DD, et al. Analysis of Oxidative DNA Damage in Patients with Colorectal Cancer. Clin Colorectal Cancer. 2008; 7: 267-272.
28. Wang J, Xing SS, Guo SB, et al. Oxidative DNA damage of lymphocytes in peripheral blood and ascites in cancer patients. Curr Oncol. 2012; 19: 10-14.
29. Liu X, Zhao J, Zheng R. DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res. 2003; 539: 1-8. (Pubitemid 37020893)
30. Matsunami T, Sato Y, Sato T, et al. Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure. Int J Clin Exp Pathol. 2010; 3: 177-188.
31. Conlin A, Smith G, Carey FA, et al. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut. 2005; 54: 1283-1286. (Pubitemid 41192491)
32. Iacopetta B, Russo A, Bazan V, et al. Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol. 2006; 17: 842-847.
33. De Filippo C, Luceri C, Caderni G, et al. Mutations of the APC gene in human sporadic colorectal cancers. Scand J Gastroenterol. 2002; 37: 1048-1053.
34. Kalady MF, Dejulius KL, Sanchez JA, et al. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum. 2012; 55: 128-133.
35. Nemec AA, Donigan KA, Murphy DL, et al. Colon cancer-associated DNA polymerase β variant induces genomic instability and cellular transformation. J Biol Chem. 2012; 287: 23840-23849.
36. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000; 159: 79-86.